Immunoreactivity of ICAM-1 in human tumors, metastases and normal tissues

International Journal of Clinical and Experimental Pathology

Volumn 2, Issue 6, 2009, Pages 553-560

  Hayes, Sarah H ^a   Seigel, Gail M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

ICAM 1; Immunohistochemistry; Metastasis; Tissue array; Tumor

Indexed keywords

EID: 67650234451     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Dymicka-Piekarska V and Kemona H. Does colorectal cancer clinical advancement affect adhesion molecules (sP- selectin, sE- selectin and ICAM-1) concentration? Thromb Res 2009 [Epub ahead of print]
2. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R and Luscinskas FW. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow. Blood 2005;106: 584-592.
3. Basoglu M, Atamanalp SS, Yildirgan MI, Aydinli B, Ozturk G, Akcay F and Oren D. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer. Eur Surg Res 2007;39:136-140.
4. Dowlati A, Gray R, Sandler AB, Schiller JH and Johnson DH. Cell adhesion molecules, vascular endothelial growth factor, and basic fibroblast growth factor in patients with non-small cell lung cancer treated with chemotherapy with or without bevacizumab-an Eastern Cooperative Oncology Group Study. Clin Cancer Res 2008; 14:1407-1412.
5. Choi Y-L, Xuan YH, Shin YK, Chae SW, Kook MC, Sung RH, Youn SJ, Choi JW and Kim SH. An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions. J Histochem Cytochem 2004;52:591-601.
6. Hemmerlein B, Scherbening J, Kugler A, and Radzun H-J. Expression of VCAM-1, ICAM-1, E- and P-selectin and tumour-associated macrophages in renal cell carcinoma. Histopathology 2000;37:78-83.
7. Lin Y-C, Shun C-T, Wu M-S and Chen C-C. A novel anticancer effect of Thalidomide: Inhibition of intercellular adhesion molecule-1 mediated cell invasion and metastasis through suppression of nuclear factor-kB. Clin Cancer Res 2006;12:7165-7173.
8. Tempia-Caliera AA, Horvath LZ, Zimmermann A, Tihanyi TT, Korc M, Friess H and Buchler MW. Adhesion molecules in human pancreatic cancer. J Surg Oncol 2002;79:93-100.
9. Brooks KJ, Coleman EJ and Vitetta ES. The antitumor activity of an anti-CD54 antibody in SCID mice xenographed with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. Int J Cancer 2008;123: 2438-2445.
10. Liang S, Slattery MJ, Wagner D, Simon SI and Dong C. Hydrodynamic shear rate regulates melanoma-leukocyte aggregation, melanoma adhesion to the endothelium, and subsequent extravasation. Ann Biomed Eng 2008;36: 661-671.
11. Wang S, Coleman EJ, Pop LM, Brooks KJ, Vitetta ES and Niederkorn JY. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice. Int J Cancer 2006;118:932-941.
12. Smith MEF and Thomas JA. Cellular expression of lymphocyte function associated antigens and the intercellular adhesion molecule-1 in normal tissue. J Clin Pathol 1990;43:893-900.
13. Stolp HB and Dziegielewska KM. Review: Role of developmental inflammation and blood-brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases. Neuropathol Appl Neurobiol 2009;35: 132-146.
14. Madigan MC and Penfold PL. Human retinoblastoma: a morphological study of apoptotic, leukocytic, and vascular elements. Ultrastruct Pathol 1997;21:95-107.
15. Greenwood J, Pryce G, Devine L, Male, DK, dos Santos WLC, Calder VL and Adamson P. SV40 large T immortalized cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics. J Neuroimmun 1996;71: 51-63.
16. Hamai A, Meslin F, Benlalam H, Jalil A, Mehrpour M, Faure F, Lecluse Y, Vielh P, Avril M, Robert C and Chouaib S. ICAM-1 has a critical role in the regulation of metastatic melanoma tumor susceptibility to CTL lysis by interfering with PI3K/AKT pathway. Cancer Res 2008; 68:9854-9864.